OCUL Competitors & Alternatives
Compare Ocular Therapeutix Inc with similar stocks in the same industry
Biotechnology
OCUL
Main Stock$6.61
Tradestie Score
62
Market Cap
$1.92B
Revenue Growth
0.0%
Analyst Upside
+293.3%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$36.03
|
$1.55B | 12.4 | 69 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$30.68
|
$1.55B | - | 64 | Compare |
|
NVAX
Novavax Inc
|
$9.99
|
$1.54B | - | 36 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$17.33
|
$1.50B | 7.4 | 46 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$21.93
|
$1.50B | - | 49 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$28.57
|
$1.49B | - | 51 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$19.36
|
$1.43B | - | 48 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$17.06
|
$1.42B | - | 49 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$13.57
|
$1.35B | - | 61 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$26.53
|
$1.32B | - | 54 | Compare |
More OCUL Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry